ArticleBMC nephrology2026
The impact of neutrophil-to-lymphocyte ratio on staging and mortality risk stratification of cardiovascular-kidney-metabolic syndrome.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular-kidney-metabolic (CKM) syndrome is a systemic disorder involving pathophysiological interactions among metabolic risk factors, renal system, and cardiovascular system, with consequent systemic inflammatory and oxidative stress responses. Neutrophil-to-lymphocyte ratio (NLR) has been reported to be a prognostic indicator of systemic inflammation and immunity, but its mortality predictive value in CKM syndrome has not been investigated.
methodsTotally 19,525 participants were included from NHANES database (1999-2018), and were divided into 4 groups by their NLR level (quartile 1 to 4). Study outcomes were all-cause and cardiovascular mortality. Binary and ordinal logistic regression was used to investigate the relationship between NLR and CKM stages, and cox regression model and restricted cubic spline (RCS) were used to assessed the association between the NLR and outcomes. Subgroup analysis was conducted to investigate the risk in different CKM stage.
resultsDuring the median follow-up of 9.2 years, 10.93% patients (n = 2,926) died, of which 3.35% patients (n = 944) died from cardiovascular disease. Compared to patients with NLR in quartile 1 (as reference), elevated NLR quartiles were associated with a higher prevalence of advanced CKM stage. After adjustment, compared to NLR in quartile 1, the hazard radio of cardiovascular mortality was 1.46 ([95%CI 1.03-2.06], P = 0.035) for quartile 2, 1.45 ([95%CI 1.04-2.03], P = 0.030) for quartile 3, and 1.95 ([95%CI 1.41-2.70], P < 0.001) for quartile 4. RCS analysis also showed a linear association between NLR and cardiovascular mortality (P for nonlinearity = 0.722). For patients at advanced CKM stage, elevated NLR level was significantly associated with increased risk of mortality compared with those at early CKM stage.
conclusionThis study finds that higher NLR level is associated with increased risk of mortality, and NLR serves as an independent predictor of advanced CKM stages, indicating that NLR can be used as a risk stratification tool for different CKM stages. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.